Provided by Tiger Trade Technology Pte. Ltd.

VanEck Pharmaceutical ETF

115.43
+0.92010.80%
Volume:50.20K
Turnover:5.81M
Market Cap:1.04B
PE:93.53
High:116.46
Open:114.98
Low:114.98
Close:114.51
52wk High:118.00
52wk Low:85.91
Shares:8.99M
Float Shares:8.99M
Volume Ratio:0.94
T/O Rate:0.56%
Dividend:2.17
Dividend Rate:1.88%
EPS(TTM):1.23
EPS(LYR):0.7765
ROE:--
ROA:--
PB:--
PE(LYR):148.66

Loading ...

Ozempic Maker Novo Nordisk Downgraded to Sell After 70% Stock-Price Dive from Peak

Dow Jones
·
Aug 27

Novo Nordisk (0QIU) was downgraded to a Sell Rating at Deutsche Bank

TIPRANKS
·
Aug 27

Novo Nordisk Faces Growth Concerns Ahead of Important Investor Day

Dow Jones
·
Aug 27

AbbVie Seeks EMA Approval for Skyrizi Subcutaneous Induction in Crohn’s Disease

Reuters
·
Aug 27

Abbvie Submits Regulatory Application to Ema for Skyrizi® (Risankizumab) Subcutaneous Induction for Adults with Moderately to Severely Active Crohn's Disease

THOMSON REUTERS
·
Aug 27

RBC Capital Reaffirms Their Hold Rating on Merck & Company (MRK)

TIPRANKS
·
Aug 27

Eli Lilly & Co. Stock Slips 3.6%, Underperforms Peers

Dow Jones
·
Aug 27

AbbVie Inc. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Aug 27

Sector Update: Healthcare

MT Newswires Live
·
Aug 27

Eli Lilly Expands Alzheimer’s Pipeline With New Amyloid Phase 1 Trial

TIPRANKS
·
Aug 27

Novo Nordisk A/S Series B Stock Falls Wednesday, Underperforms Market

Dow Jones
·
Aug 27

Eli Lilly Stock (LLY) in Focus as Alzheimer’s Blood Test Gets FDA Approval

TIPRANKS
·
Aug 26

Nike, Merck Share Losses Contribute to Dow's 150-Point Drop

Dow Jones
·
Aug 26

European Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading

MT Newswires Live
·
Aug 26

Eli Lilly and Co Stock (LLY) Opened Down by 3.57% on Aug 26: Facts Behind the Movement

TradingKey
·
Aug 26

Eli Lilly Study Shows Lower Healthcare Costs With Zepbound in Older Adults

MT Newswires Live
·
Aug 26

Gubra Earns USD 50 Million Milestone as AbbVie Starts Phase 2 Trial of Obesity Drug ABBV-295

Reuters
·
Aug 26

Zepbound Linked to Lower Healthcare Costs in Adults over Age 55 with Obesity According to a Real-World Study

THOMSON REUTERS
·
Aug 26

Uni-Bio Science H1 Revenue Falls 12% on Pricing Changes

Reuters
·
Aug 26

DBS Reaffirms Their Hold Rating on Novo Nordisk (0QIU)

TIPRANKS
·
Aug 26